Counts SE - Search Results

1

Dimebon alters hippocampal amyloid pathology in 3xTg-AD mice.

Perez SE, Nadeem M, Sadleir KR, Matras J, Kelley CM, Counts SE, Vassar R, Mufson EJ. Perez SE, et al. Among authors: counts se. Int J Physiol Pathophysiol Pharmacol. 2012;4(3):115-27. Epub 2012 Sep 20. Int J Physiol Pathophysiol Pharmacol. 2012. PMID: 23071869 Free PMC article.

2

Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway.

Jaffar S, Counts SE, Ma SY, Dadko E, Gordon MN, Morgan D, Mufson EJ. Jaffar S, et al. Among authors: counts se. Exp Neurol. 2001 Aug;170(2):227-43. doi: 10.1006/exnr.2001.7710. Exp Neurol. 2001. PMID: 11476589

3

Galanin: neurobiologic mechanisms and therapeutic potential for Alzheimer's disease.

Counts SE, Perez SE, Kahl U, Bartfai T, Bowser RP, Deecher DC, Mash DC, Crawley JN, Mufson EJ. Counts SE, et al. CNS Drug Rev. 2001 Winter;7(4):445-70. doi: 10.1111/j.1527-3458.2001.tb00210.x. CNS Drug Rev. 2001. PMID: 11830760 Free PMC article. Review.

4

Galanin inhibits tyrosine hydroxylase expression in midbrain dopaminergic neurons.

Counts SE, McGuire SO, Sortwell CE, Crawley JN, Collier TJ, Mufson EJ. Counts SE, et al. J Neurochem. 2002 Oct;83(2):442-51. doi: 10.1046/j.1471-4159.2002.01148.x. J Neurochem. 2002. PMID: 12423254 Free article.

5

Gene expression profiles of cholinergic nucleus basalis neurons in Alzheimer's disease.

Mufson EJ, Counts SE, Ginsberg SD. Mufson EJ, et al. Among authors: counts se. Neurochem Res. 2002 Oct;27(10):1035-48. doi: 10.1023/a:1020952704398. Neurochem Res. 2002. PMID: 12462403

6

Preservation of brain nerve growth factor in mild cognitive impairment and Alzheimer disease.

Mufson EJ, Ikonomovic MD, Styren SD, Counts SE, Wuu J, Leurgans S, Bennett DA, Cochran EJ, DeKosky ST. Mufson EJ, et al. Among authors: counts se. Arch Neurol. 2003 Aug;60(8):1143-8. doi: 10.1001/archneur.60.8.1143. Arch Neurol. 2003. PMID: 12925373

7

Galanin in Alzheimer disease.

Counts SE, Perez SE, Ginsberg SD, De Lacalle S, Mufson EJ. Counts SE, et al. Mol Interv. 2003 May;3(3):137-56. doi: 10.1124/mi.3.3.137. Mol Interv. 2003. PMID: 14993421 Review.

8

Reduction of cortical TrkA but not p75(NTR) protein in early-stage Alzheimer's disease.

Counts SE, Nadeem M, Wuu J, Ginsberg SD, Saragovi HU, Mufson EJ. Counts SE, et al. Ann Neurol. 2004 Oct;56(4):520-31. doi: 10.1002/ana.20233. Ann Neurol. 2004. PMID: 15455399

9

The role of nerve growth factor receptors in cholinergic basal forebrain degeneration in prodromal Alzheimer disease.

Counts SE, Mufson EJ. Counts SE, et al. J Neuropathol Exp Neurol. 2005 Apr;64(4):263-72. doi: 10.1093/jnen/64.4.263. J Neuropathol Exp Neurol. 2005. PMID: 15835262 Review.

10

Ectopic galanin expression and normal galanin receptor 2 and galanin receptor 3 mRNA levels in the forebrain of galanin transgenic mice.

He B, Counts SE, Perez SE, Hohmann JG, Koprich JB, Lipton JW, Steiner RA, Crawley JN, Mufson EJ. He B, et al. Among authors: counts se. Neuroscience. 2005;133(2):371-80. doi: 10.1016/j.neuroscience.2005.01.068. Neuroscience. 2005. PMID: 15885921

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters